Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Williams-Gray

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Neuropathology and Applied Neurobiology|January 12, 2016
Review: The spectrum of clinical features seen with alpha synuclein pathologyR A Barker, C H Williams-Gray
Brain, Behavior, and Immunity|July 5, 2019
Toll-like receptors and their therapeutic potential in Parkinson's disease and α-synucleinopathiesAntonina Kouli, C B Horne, C H Williams-Gray
Journal of Neuroimmunology|August 7, 2023
Natural killer cells have an activated profile in early Parkinson's diseaseJ Holbrook, B Patel, M Camacho, et al.
Cerebral Cortex (New York, N.Y. : 1991)|February 22, 2012
Prefrontal dopamine levels determine the balance between cognitive stability and flexibilityS J Fallon, C H Williams-Gray, R A Barker, et al.
Neuropsychologia|August 6, 2013
Putative cortical dopamine levels affect cortical recruitment during planningS J Fallon, A Hampshire, C H Williams-Gray, et al.
Brain : a Journal of Neurology|May 31, 2007
Evolution of cognitive dysfunction in an incident Parkinson's disease cohortC H Williams-Gray, T Foltynie, C E G Brayne, et al.
Journal of Neuroinflammation|May 30, 2018
Abnormalities of age-related T cell senescence in Parkinson's diseaseC H Williams-Gray, R S Wijeyekoon, K M Scott, et al.
Neurobiology of Aging|August 30, 2008
The val158met COMT polymorphism's effect on atrophy in healthy aging and Parkinson's diseaseJ B Rowe, L Hughes, C H Williams-Gray, et al.
Brain : a Journal of Neurology|June 26, 2008
Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognitionJ B Rowe, L Hughes, B C P Ghosh, et al.
Journal of Neurology|April 14, 2007
Investigation of TGFB2 as a candidate gene in multiple sclerosis and Parkinson's diseaseA Goris, C H Williams-Gray, T Foltynie, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Neuropathology and Applied Neurobiology|January 12, 2016
Review: The spectrum of clinical features seen with alpha synuclein pathologyR A Barker, C H Williams-Gray
Brain, Behavior, and Immunity|July 5, 2019
Toll-like receptors and their therapeutic potential in Parkinson's disease and α-synucleinopathiesAntonina Kouli, C B Horne, C H Williams-Gray
Journal of Neuroimmunology|August 7, 2023
Natural killer cells have an activated profile in early Parkinson's diseaseJ Holbrook, B Patel, M Camacho, et al.
Cerebral Cortex (New York, N.Y. : 1991)|February 22, 2012
Prefrontal dopamine levels determine the balance between cognitive stability and flexibilityS J Fallon, C H Williams-Gray, R A Barker, et al.
Neuropsychologia|August 6, 2013
Putative cortical dopamine levels affect cortical recruitment during planningS J Fallon, A Hampshire, C H Williams-Gray, et al.
Brain : a Journal of Neurology|May 31, 2007
Evolution of cognitive dysfunction in an incident Parkinson's disease cohortC H Williams-Gray, T Foltynie, C E G Brayne, et al.
Journal of Neuroinflammation|May 30, 2018
Abnormalities of age-related T cell senescence in Parkinson's diseaseC H Williams-Gray, R S Wijeyekoon, K M Scott, et al.
Neurobiology of Aging|August 30, 2008
The val158met COMT polymorphism's effect on atrophy in healthy aging and Parkinson's diseaseJ B Rowe, L Hughes, C H Williams-Gray, et al.
Brain : a Journal of Neurology|June 26, 2008
Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognitionJ B Rowe, L Hughes, B C P Ghosh, et al.
Journal of Neurology|April 14, 2007
Investigation of TGFB2 as a candidate gene in multiple sclerosis and Parkinson's diseaseA Goris, C H Williams-Gray, T Foltynie, et al.
Pageof 2